Scalper1 News
The war of words heated up between generic drug makers Mylan (MYL) and Perrigo (PRGO) this week as both companies strove to win a shareholder vote set for Friday on Mylan’s hostile takeover attempt. Mylan first proposed buying Perrigo back in April for $60 in cash plus 2.2 Mylan shares for each Perrigo share, which it later lifted to $75 a share plus 2.3 Mylan shares — at the time, about $36 billion. By the time Mylan launched its tender offer on Scalper1 News
Scalper1 News